146 related articles for article (PubMed ID: 2095782)
1. Modulatory effects of phosphatidylserine on the binding of muscarinic cholinergic receptor ligands. Studies in vitro and in vivo.
Raskovsky S; Rivas E; Bernik D; Medina J; Jerusalinsky D
Mol Chem Neuropathol; 1990; 13(1-2):17-32. PubMed ID: 2095782
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro modulation of central type benzodiazepine receptors by phosphatidylserine.
Levi de Stein M; Medina JH; De Robertis E
Brain Res Mol Brain Res; 1989 Jan; 5(1):9-15. PubMed ID: 2538706
[TBL] [Abstract][Full Text] [Related]
3. An [3H]oxotremorine binding method reveals regulatory changes by guanine nucleotides in cholinergic muscarinic receptors of cerebral cortex.
Raskovsky S; Aguilar JS; Jerusalinsky D; De Robertis E
Neurochem Res; 1988 Jun; 13(6):525-30. PubMed ID: 3405377
[TBL] [Abstract][Full Text] [Related]
4. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
5. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands.
Jerusalinsky D; Cerveñasky C; Peña C; Raskovsky S; Dajas F
Neurochem Int; 1992 Feb; 20(2):237-46. PubMed ID: 1304863
[TBL] [Abstract][Full Text] [Related]
6. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
Wang H; Cui WY; Liu CH
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
[TBL] [Abstract][Full Text] [Related]
7. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
Das S; Matwyshyn GA; Bhargava HN
Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
Lockhart B; Closier M; Howard K; Steward C; Lestage P
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
[TBL] [Abstract][Full Text] [Related]
9. An approach to analysis of radiolabeled ligand interactions with specific receptors.
Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cholinergic muscarinic receptors in the rabbit iris.
Honkanen RE; Abdel-Latif AA
Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
13. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
14. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
16. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
Ben-Barak J; Gazit H; Silman I; Dudai Y
Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by local anesthetics, phentolamine and propranolol of [3H]quinuclydinyl benzylate binding to central muscarinic receptors.
Aguilar JS; Criado M; De Robertis E
Eur J Pharmacol; 1980 Dec; 68(3):317-26. PubMed ID: 7202495
[TBL] [Abstract][Full Text] [Related]
18. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
[TBL] [Abstract][Full Text] [Related]
19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of ethanol on muscarinic cholinergic binding to rat and locust neural membranes.
Aguilar JS; Fonseca MI; Lunt GG
Neurochem Res; 1989 Aug; 14(8):765-70. PubMed ID: 2812253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
